PubMed

Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study.

Forceville X, Laviolle B, Annane D, Vitoux D, Bleichner G, Korach JM, Cantais E, Georges H, Soubirou JL, Combes A, Bellissant E.

Crit Care. 2007;11(4):R73.PMID: 17617901 [PubMed - indexed for MEDLINE]Related articlesFree article

Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock.

Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, Strauss R, Meier-Hellmann A, Insel R, Radke J, Schüttler J, Gärtner R.

Crit Care Med. 2007 Jan;35(1):118-26.PMID: 17095947 [PubMed - indexed for MEDLINE]Related articles

Effects of high doses of selenium, as sodium selenite, in septic shock patients a placebo-controlled, randomized, double-blind, multi-center phase II study--selenium and sepsis.

Forceville X.

J Trace Elem Med Biol. 2007;21 Suppl 1:62-5. Epub 2007 Oct 31.PMID: 18039501 [PubMed - indexed for MEDLINE]Related articles

Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.

Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K.

Crit Care Med. 1999 Apr;27(4):723-32.PMID: 10321661 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).

Watson D, Grover R, Anzueto A, Lorente J, Smithies M, Bellomo R, Guntupalli K, Grossman S, Donaldson J, Le Gall JR; Glaxo Wellcome International Septic Shock Study Group.

Crit Care Med. 2004 Jan;32(1):13-20.PMID: 14707555 [PubMed - indexed for MEDLINE]Related articles

Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).

Bakker J, Grover R, McLuckie A, Holzapfel L, Andersson J, Lodato R, Watson D, Grossman S, Donaldson J, Takala J; Glaxo Wellcome International Septic Shock Study Group.

Crit Care Med. 2004 Jan;32(1):1-12.PMID: 14707554 [PubMed - indexed for MEDLINE]Related articles

Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome.

Annane D, Sébille V, Bellissant E; Ger-Inf-05 Study Group.

Crit Care Med. 2006 Jan;34(1):22-30.PMID: 16374152 [PubMed - indexed for MEDLINE]Related articles

Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients.

Abraham E, Laterre PF, Garbino J, Pingleton S, Butler T, Dugernier T, Margolis B, Kudsk K, Zimmerli W, Anderson P, Reynaert M, Lew D, Lesslauer W, Passe S, Cooper P, Burdeska A, Modi M, Leighton A, Salgo M, Van der Auwera P; Lenercept Study Group.

Crit Care Med. 2001 Mar;29(3):503-10.PMID: 11373411 [PubMed - indexed for MEDLINE]Related articles

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock.

López A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, Silverman MS, Takala J, Donaldson J, Arneson C, Grove G, Grossman S, Grover R.

Crit Care Med. 2004 Jan;32(1):21-30.PMID: 14707556 [PubMed - indexed for MEDLINE]Related articles

[Investigation of antioxidant therapy with sodium selenite in acute pancreatitis. A prospective randomized blind trial]

Lindner D, Lindner J, Baumann G, Dawczynski H, Bauch K.

Med Klin (Munich). 2004 Dec 15;99(12):708-12. German. PMID: 15599680 [PubMed - indexed for MEDLINE]Related articles

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet-Riffaud P, Bellissant E.

JAMA. 2002 Aug 21;288(7):862-71. Erratum in: JAMA. 2008 Oct 8;300(14):1652. Chaumet-Riffaut, Philippe [corrected to Chaumet-Riffaud, Philippe]. PMID: 12186604 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock.

Mussack T, Briegel J, Schelling G, Biberthaler P, Jochum M.

Clin Chem Lab Med. 2005;43(3):259-68.PMID: 15843228 [PubMed - indexed for MEDLINE]Related articles

Detrimental effects of high-dose methylprednisolone sodium succinate on serum concentrations of hepatic and renal function indicators in severe sepsis and septic shock. The Methylprednisolone Severe Sepsis Study Group.

Slotman GJ, Fisher CJ Jr, Bone RC, Clemmer TP, Metz CA.

Crit Care Med. 1993 Feb;21(2):191-5.PMID: 8428468 [PubMed - indexed for MEDLINE]Related articles

INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.

Cohen J, Carlet J.

Crit Care Med. 1996 Sep;24(9):1431-40.PMID: 8797612 [PubMed - indexed for MEDLINE]Related articles

Effect of selenium supplementation on biochemical markers and outcome in critically ill patients.

Mishra V, Baines M, Perry SE, McLaughlin PJ, Carson J, Wenstone R, Shenkin A.

Clin Nutr. 2007 Feb;26(1):41-50. Epub 2006 Dec 14.PMID: 17174015 [PubMed - indexed for MEDLINE]Related articles

Vasopressin versus norepinephrine infusion in patients with septic shock.

Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D; VASST Investigators.

N Engl J Med. 2008 Feb 28;358(9):877-87.PMID: 18305265 [PubMed - indexed for MEDLINE]Related articlesFree article

Adjunctive homeopathic treatment in patients with severe sepsis: a randomized, double-blind, placebo-controlled trial in an intensive care unit.

Frass M, Linkesch M, Banyai S, Resch G, Dielacher C, Löbl T, Endler C, Haidvogl M, Muchitsch I, Schuster E.

Homeopathy. 2005 Apr;94(2):75-80.PMID: 15892486 [PubMed - indexed for MEDLINE]Related articles

Extended drotrecogin alfa (activated) treatment in patients with prolonged septic shock.

Dhainaut JF, Antonelli M, Wright P, Desachy A, Reignier J, Lavoue S, Charpentier J, Belger M, Cobas-Meyer M, Maier C, Mignini MA, Janes J.

Intensive Care Med. 2009 Jul;35(7):1187-95. Epub 2009 Mar 5. Erratum in: Intensive Care Med. 2009 Jul;35(7):1319-21. PMID: 19263034 [PubMed - indexed for MEDLINE]Related articles

Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: a prospective, multicenter, double-blind, randomized phase II trial. TCV-309 Septic Shock Study Group.

Poeze M, Froon AH, Ramsay G, Buurman WA, Greve JW.

Shock. 2000 Oct;14(4):421-8.PMID: 11049104 [PubMed - indexed for MEDLINE]Related articles

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Pénzes I, Kübler A, Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, Opal SM; KyberSept Trial Study Group.

JAMA. 2001 Oct 17;286(15):1869-78. Erratum in: JAMA 2002 Jan 9;287(2):192. PMID: 11597289 [PubMed - indexed for MEDLINE]Related articlesFree article